Option Care Health, Inc.
NASDAQ:OPCH · NASDAQ Global Select
+$0.45 today
Vol 3.56M · Avg 3.09M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Stock Ticker Earnings Waterfall
NASDAQ:OPCH · Revenue to Net Income
Key Ratios
Analysis
$5.7B of revenue converted into $206.2M of net income for the selected period. Gross margin is 18.0% and net margin is 3.6%, showing how much revenue survives after costs and taxes. EPS is $1.29, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.6B +13.0% | $5.0B +16.2% | $4.3B +9.1% | $3.9B +14.7% | $3.4B | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $4.6B +16.2% | $4.0B +20.0% | $3.3B +7.9% | $3.1B +15.7% | $2.7B | $725.6M | $804.0M | $882.4M |
| Gross Profit | $1.0B +0.7% | $1.0B +3.2% | $981.2M +13.2% | $866.9M +11.2% | $779.6M | $8.9B | $7.6B | $6.2B |
| Gross Margin | 18.1% -2.2pp | 20.3% -2.5pp | 22.8% +0.8pp | 22.0% -0.7pp | 22.7% | 9.8% | 28.9% | 38.3% |
| Research & Development | $0 | $0 | $0 | $0 | $0 | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $682.5M +8.3% | $630.3M +3.8% | $607.4M +7.3% | $566.1M +7.7% | $525.7M | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $682.5M -1.3% | $691.2M +3.7% | $666.6M +6.4% | $626.7M +6.4% | $588.8M | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $70.7M +11.3% | $63.5M +2.1% | $62.2M -4.9% | $65.4M -4.9% | $68.8M | $374.2M | $1.2B | $631.8M |
| EBITDA | $416.8M +5.2% | $396.1M -16.1% | $472.2M +45.3% | $325.0M +28.8% | $252.3M | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | 7.4% -0.5pp | 7.9% -3.0pp | 11.0% +2.7pp | 8.2% +0.9pp | 7.3% | 5.6% | 46.3% | 42.0% |
| Operating Income | $337.9M +5.0% | $321.8M +2.3% | $314.6M +31.0% | $240.2M +25.9% | $190.8M | $12.3B | $14.0B | -$15.7B |
| Operating Margin | 6.0% -0.5pp | 6.4% -0.9pp | 7.3% +1.2pp | 6.1% +0.5pp | 5.5% | 16.6% | 24.1% | 22.0% |
| Interest Income | $0 | $0 | $0 | $0 | $0 | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $63.2M +4.4% | $60.6M -2.7% | $62.2M +13.3% | $54.9M -1.0% | $55.5M | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | -$55.0M -43.9% | -$38.2M -186.6% | $44.1M +228.1% | -$34.5M +53.6% | -$74.3M | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | $282.9M -0.2% | $283.6M -20.9% | $358.7M +74.3% | $205.8M +76.6% | $116.5M | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | 5.0% -0.7pp | 5.7% -2.7pp | 8.3% +3.1pp | 5.2% +1.8pp | 3.4% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | $75.3M +4.9% | $71.8M -21.7% | $91.7M +66.0% | $55.2M +335.9% | -$23.4M | $1.3B | -$1.6B | $745.2M |
| Net Income | $207.6M -2.0% | $211.8M -20.7% | $267.1M +77.4% | $150.6M +7.6% | $139.9M | $4.9B | $4.8B | $4.7B |
| Net Margin | 3.7% -0.6pp | 4.2% -2.0pp | 6.2% +2.4pp | 3.8% -0.3pp | 4.1% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | $1 +4.1% | $1 -17.4% | $1 +79.5% | $1 +6.4% | $1 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | $1 +3.3% | $1 -16.9% | $1 +78.3% | $1 +7.8% | $1 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $162.1M -5.5% | $171.6M -4.1% | $179.0M -1.2% | $181.1M +0.7% | $179.9M | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $163.4M -5.5% | $172.8M -4.2% | $180.4M -0.9% | $182.1M +0.5% | $181.2M | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Kymera Therapeutics, Inc.
NASDAQ:KYMR
$7.48B
Oscar Health, Inc.
NYSE:OSCR
$7.34B
Immunovant, Inc.
NASDAQ:IMVT
$7.18B
Lantheus Holdings, Inc.
NASDAQ:LNTH
$6.77B
Hinge Health, Inc.
NYSE:HNGE
$5.21B
Indivior Pharmaceuticals Inc
NASDAQ:INDV
$4.76B
Akero Therapeutics, Inc.
AKRO
$4.50B
ACADIA Pharmaceuticals Inc.
NASDAQ:ACAD
$3.67B
TransMedics Group, Inc.
NASDAQ:TMDX
$2.70B
ADMA Biologics, Inc.
NASDAQ:ADMA
$1.96B
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does OPCH generate?
Option Care Health, Inc. (OPCH) reported $5.65B of revenue in fiscal 2025.
Is OPCH profitable?
Option Care Health, Inc. (OPCH) reported $207.59M of net income, with a net margin of 3.7%.
Explore More
Continue the stock analysis
Jump to another research area for this company.